Project Updates

Genentech's Biologics Manufacturing Facility, Oceanside, US

Location: Oceanside, California

Project type: Commercial biologics manufacturing facility

Expected Start of Operations: Early 2025

Owner: Genentech

Genentech, a member of Roche Group, will build a next-generation biologics manufacturing facility at its existing campus in Oceanside, California, for sustainable production of small-batch commercial biologics. A ground-breaking ceremony for the new manufacturing facility took place in February 2023.

BioNTech mRNA Vaccine Manufacturing Facility, Rwanda

Location: Kigali, Rwanda 

Project type: Vaccine manufacturing facility 
Start of Construction: June 2022 

Owner: BioNTech

BioNTech is building its first modular mRNA vaccine manufacturing facility in Kigali, Rwanda, to promote sustainable vaccine production and end-to-end vaccine supply in African Union member states. The project is expected to create around 100 jobs by 2024.

Abzena’s cGMP Biologics Manufacturing Facility, Sanford, US

Location: Sanford, North Carolina 

Project type: Biologics manufacturing site 

Estimated Investment: $213m 

Area: 120,0002

Abzena is building a current good manufacturing practice (cGMP) manufacturing facility for mammalian biologics in Sanford, North Carolina. The facility will expand the company’s manufacturing capacity to meet customer demand. Abzena’s new manufacturing site is expected to create 325 local jobs.

Go to article: Home | CoverGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: ControlantGo to article: SyntegonGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: CfPIEGo to article: In DepthGo to article: Dawn of a new indication: How to study drugs for aging Go to article: Cleanroom tech tackles environmental impact of consumables Go to article: Tapping into digital therapeutics to improve neurological outcomes Go to article: CMO Moves: Regulatory catalysts for drug manufacturing – March Go to article: Ethics of ultra-rare disease drug development and expanded accessGo to article: APAC early-stage innovators raise one-third less VC funds than US players Go to article: Zenatek Company InsightGo to article: BEA TechnologiesGo to article: Bio Image Systems Inc.Go to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: Foreword: the transformative power of cloud Go to article: An introduction to cloud computingGo to article: A history of cloud computingGo to article: The impact of cloud computing on the pharmaceutical industry Go to article: Applications of cloud computing in the pharmaceutical industry Go to article: Latest news: cloud computing in pharma Go to article: Q&A with GlobalData thematic analystGo to article: Is RFID the future of smart labelling?Go to article: Cloud robotics labs are accelerating drug discovery and development Go to article: Leading pharma companies in the cloud computing theme Go to article: Deal activity related to cloud in the pharmaceutical industry since 2020 Go to article: Cloud hiring trends in the global pharmaceutical industry since 2020 Go to article: Cloud patent applications in the global pharmaceutical industry since 2020Go to article: Mentions of cloud in pharmaceutical industry company filings since 2020 Go to article: GlobalData Thematic IntelligenceGo to article: Pharma Sponsored SupplementsGo to article: HOF SonderanlagenbauGo to article: Thermo Fisher ScientificGo to article: ListingsGo to article: EventsGo to article: RankingsGo to article: Buyer's GuidesGo to article: Next issue